复方远志合剂对急性支气管炎的疗效及安全性评价  

The efficacy and safety of Fufangyuanzhi Mixture for acute bronchitis

作　　者：孙毅[1] 褚福明[1] 程慎令[1] 郭玲[1] 黄振[1] 

机构地区：[1]山东省滕州市中心人民医院药剂科,山东滕州277500

出　　处：《中国医药导报》2010年第5期16-18,共3页China Medical Herald

摘　　要：目的:观察应用复方远志合剂对急性支气管炎的疗效及安全性。方法:将100例急性支气管炎患者随机分为治疗组(50例)和对照组(50例),治疗组在支气管炎常规治疗基础上给予口服复方远志合剂治疗,疗程为1周,于治疗前后分别测定末梢血白细胞计数(WBC)及分类,部分患者做X线检查。结果:治疗组临床痊愈率和总有效率分别为80.0%和98.0%;对照组临床痊愈率和总有效率分别为60.0%和92.0%;治疗组治疗后临床痊愈率及总有效率明显优于对照组(P<0.05)。结论:复方远志合剂对急性支气管炎有明显的镇咳祛痰效果,安全性良好。Objective： To observe the efficacy and safety of Fufangyuanzhi Mixture for acute bronchitis. Methods： 100 patients with acute bronchitis were randomly divided into treatment group （n=50） and control group （n=50）. In addition to the usual treatment, the Fufangyuanzhi Mixture was given to the treatment group for a course of one week. White blood cell count and its categorization of the peripheral blood were taken before and after treatment. X-ray examination was taken on some cases. Results： The clinical cure rate and total effective rate of treatment group were 80.0% and 98.0% respectively. The clinical cure rate and total effective rate of control group were 60.0% and 92.0% respectively. The clinical cure rate and total effective rate of treatment group were significantly higher than those of control group （P〈0.05）. Conclusion： The mixture is markedly effective and safe for cough and phlegm of acute bronchitis.

关 键 词：复方远志合剂 中药治疗 疗效评价 

分 类 号：R562.21[医药卫生—呼吸系统]